J. Given

Prospective, open-label assessment of albuterol sulfate hydrofluoroalkane metered-dose inhaler with new integrated dose counter.

J. Given, H. Taveras, H. Iverson, 2013, Allergy and asthma proceedings.

Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma.

W. Lumry, J. Given, M. White, 2000, American journal of respiratory and critical care medicine.

Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis.

R. Naclerio, J. Given, H. Kaiser, 2007, The Journal of allergy and clinical immunology.

Efficacy and Safety of Fluticasone Propionate Hydrofluoroalkane Inhalation Aerosol in Four- to Eleven-Year-Old Children with Asthma: A Randomized, Double-Blinded, Placebo-Controlled Study

C. Crim, J. Given, C. Cott, 2006 .

Prospective, open-label evaluation of a new albuterol multidose dry powder inhaler with integrated dose counter.

J. Given, H. Taveras, H. Iverson, 2016, Allergy and asthma proceedings.

Fluticasone Furoate Nasal Spray is Effective and Well Tolerated for Perennial Allergic Rhinitis in Adolescents and Adults

N. Snowise, J. Given, A. Stillerman, 2010, American journal of rhinology & allergy.

Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma

W. Lumry, G. Shapiro, J. Given, 2000 .

Forced Expiratory Flow (FEF25–75%) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis

E. Hamelmann, S. Szefler, J. Given, 2020, Pulmonary Therapy.